GSK Induction Phase - A Randomized, Double-Blind, Placebo-Controlled Study to Envestigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects with Moderately-to-Severely Active Crohn's Disease. GSK1605786. CCX114151 Induction Phase.